Actively Recruiting

Age: 18Years - 99Years
All Genders
NCT05607966

A Post-market Observational ORIGIN® CR Clinical Study

Led by Symbios Orthopedie SA · Updated on 2024-10-08

199

Participants Needed

2

Research Sites

185 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study objective is to evaluate safety and performance of the ORIGIN® CR (cruciate retaining) devices and associated instruments, more precisely to evaluate safety by the proportion of patients requiring a revision (i.e. revision rate) at 1-year post procedure and to evaluate performance by means of a Knee Society Score (KSS) Knee Score at 1 year post procedure and by means of a KSS Function Score also at 1 year post procedure. The hypothesis raised for this study, regarding the scoring, is that patients will experience a marked improvement in the natural feel of the prosthesis during the first year after the surgery, and slightly significant improvement at the following interval of 2 years. The overall patient satisfaction is expected to be improved after 2 years follow-up with ORIGIN® CR.

CONDITIONS

Official Title

A Post-market Observational ORIGIN® CR Clinical Study

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 18 years or older
  • Willing to provide informed consent
  • Clinically indicated for total knee replacement surgery
  • Females must not be pregnant or planning pregnancy within 12 months; pregnancy test required for women of childbearing age
  • Geographically stable and willing to return to the implanting site for follow-up visits at 1 year and 2 years
Not Eligible

You will not qualify if you...

  • Acute or chronic infection, local or systemic
  • Muscular, ligament, neurological, psychological, or vascular deficits
  • Bone destruction or poor bone quality affecting implant stability
  • Conditions likely to affect implant integration or function
  • Allergy or hypersensitivity to device materials
  • Renal or hepatic impairment for devices made of CoCrMo
  • Hip Knee Ankle angle less than 1656 or greater than 1956
  • Severe collateral ligament deficiency
  • Posterior cruciate ligament deficiency
  • Major anatomical deformities
  • Severe flexion contracture or recurvatum
  • Revision of previous knee prosthesis
  • Non-extractible materials conflicting with prosthesis components
  • Excessive femoral or tibial bone loss beyond component thickness
  • Bone degradation requiring anchoring stem for femoral component

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

GZA Ziekenhuizen - campus Sint-Augustinus

Antwerp, Belgium, 2610

Actively Recruiting

2

AZ Voorkempen

Malle, Belgium, 2390

Actively Recruiting

Loading map...

Research Team

B

Bojana Gannevat

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here